Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

The novel diagnostic method of colorectal cancer by methyl mercaptan

ABSTRACT: Primary outcome(s): the amount of methylmercaptan from flatus

DISEASE(S): The Novel Diagnostic Method For Colorectal Cancer: Detection Of Methyl-mercaptan From Flatus

PROVIDER: 2643463 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

ACCESS DATA

Json Xml

Similar Datasets

A novel serum metabolomics-based diagnostic approach for colorectal cancer.

Project description: Not available

| S-EPMC3394708 | biostudies-literature

SNORD15B and SNORA5C: Novel Diagnostic and Prognostic Biomarkers for Colorectal Cancer.

Project description: Not available

| S-EPMC9110153 | biostudies-literature

Circulating U2 small nuclear RNA fragments as a novel diagnostic biomarker for pancreatic and colorectal adenocarcinoma

Project description:Global microRNA expression profiling of serum were collected using Agilent miRNA microarrays (G4471A Human, Amadid 29297, Sanger 14) carrying 887 individual human miRNA probes. Two different sources of RNA were analyzed: serum from NMRI-nu/nu mice carrying a xenograft tumor derived from human primary pancreatic ductal adenocarcinomas (CA, n=6) and serum from tumor free control NMRI-nu/nu mice (N, n=6) Two condition (CA, N), each condition is represented by 6 biological replicates

2013-07-01 | E-GEOD-34052 | biostudies-arrayexpress

Mobile-CEA - A Novel Surveillance Method for Patients with Colorectal Cancer.

Project description: Not available

| S-EPMC9209784 | biostudies-literature

Circulating U2 small nuclear RNA fragments as a novel diagnostic biomarker for pancreatic and colorectal adenocarcinoma

2013-07-01 | GSE34052 | GEO

Plasma Mesothelin as a Novel Diagnostic and Prognostic Biomarker in Colorectal Cancer.

Project description: Not available

| S-EPMC5479240 | biostudies-literature

IGFBP3 methylation is a novel diagnostic and predictive biomarker in colorectal cancer.

Project description: Not available

| S-EPMC4134211 | biostudies-literature

Identification of circ_0000375 and circ_0011536 as novel diagnostic biomarkers of colorectal cancer.

Project description: Not available

| S-EPMC9048569 | biostudies-literature

Multiplex analyses of mitochondria in colorectal cancer patients uncover novel diagnostic and therapeutic opportunities

Project description:Background: Multi-omics analyses are profitable for discovering novel biomarkers and drug targets, but such integrated examinations on mitochondria of colorectal cancer (CRC) patients are lacking. Methods: We investigated global structural variants, DNA methylation, chromatin accessibility, proteome, and phosphoproteome on human CRC (n = 6-8). The alterations of mitochondria on these levels and potential upstream regulatory genes were described. Furthermore, combining with the mRNA datasets of 538 CRC and 91 colitis patients from the public databases, we identified independent prognostic factors (IPFs). Findings: Revealed by the proteogenomic analyses in our study, mitochondria altered the most among all organelles in CRC, which were also associated with patient prognosis the most. We found that the mRNA of one nuclear-coding mitochondrial gene (NCMG), HIGD1A, decreased in colitis, two subtypes of adenoma, and six subtypes of CRC, subsequently was identified as a favorable IPF for CRC. Besides, the comprehensive analyses of mitochondria by multi-omics uncovered unique proteogenomic alterations on six survival-related NCMGs. Key transcriptional factors potentially regulating the mitochondria were also unveiled, such as GLIS1, JUN, CREB1, and YAP1. Finally, p38 was highlighted as one possible central kinase involving in the modulation of mitochondrial activity in CRC patients. Interpretation: Our study presents a multilayer and molecular picture of mitochondria of CRC patients, recognizes HIGD1A as a potential prognostic biomarker, and provides new candidate genes as therapeutic targets.

2021-09-09 | PXD021314 | Pride

Multiplex analyses of mitochondria in colorectal cancer patients uncover novel diagnostic and therapeutic opportunities

2021-09-09 | PXD021318 | Pride